- Home
- OLMA vs HPS Comparison
OLMA vs HPS Comparison
Compare OLMA & HPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- HPS
- Stock Information
- Founded
- OLMA 2006
- HPS 2003
- Country
- OLMA United States
- HPS United States
- Employees
- OLMA N/A
- HPS N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- HPS Investment Managers
- Sector
- OLMA Health Care
- HPS Finance
- Exchange
- OLMA Nasdaq
- HPS Nasdaq
- Market Cap
- OLMA 465.4M
- HPS 521.2M
- IPO Year
- OLMA 2020
- HPS N/A
- Fundamental
- Price
- OLMA $6.10
- HPS $14.95
- Analyst Decision
- OLMA Strong Buy
- HPS
- Analyst Count
- OLMA 5
- HPS 0
- Target Price
- OLMA $26.25
- HPS N/A
- AVG Volume (30 Days)
- OLMA 1.1M
- HPS 58.4K
- Earning Date
- OLMA 11-12-2024
- HPS 01-01-0001
- Dividend Yield
- OLMA N/A
- HPS 8.62%
- EPS Growth
- OLMA N/A
- HPS N/A
- EPS
- OLMA N/A
- HPS N/A
- Revenue
- OLMA N/A
- HPS N/A
- Revenue This Year
- OLMA N/A
- HPS N/A
- Revenue Next Year
- OLMA N/A
- HPS N/A
- P/E Ratio
- OLMA N/A
- HPS N/A
- Revenue Growth
- OLMA N/A
- HPS N/A
- 52 Week Low
- OLMA $5.56
- HPS $11.79
- 52 Week High
- OLMA $16.78
- HPS $15.40
- Technical
- Relative Strength Index (RSI)
- OLMA 27.05
- HPS 31.08
- Support Level
- OLMA $5.56
- HPS $14.76
- Resistance Level
- OLMA $6.87
- HPS $15.64
- Average True Range (ATR)
- OLMA 0.81
- HPS 0.17
- MACD
- OLMA -0.28
- HPS -0.05
- Stochastic Oscillator
- OLMA 10.12
- HPS 18.43
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About HPS John Hancock Preferred Income Fund III Preferred Income Fund III
John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.